Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01820039
Other study ID # FertiScreen
Secondary ID
Status Recruiting
Phase N/A
First received March 14, 2013
Last updated December 13, 2013
Start date June 2013

Study information

Verified date March 2013
Source Radboud University
Contact Helga van der Pluijm-Schouten, MD
Phone +31243617769
Email H.Schouten@obgyn.umcn.nl
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

Objectives The investigators present an online application to empower and inform patients and improve guideline adherence in unexplained subfertility. Thereby the investigators expect to reduce overtreatment in fertility care with higher quality of care.

Methods The investigators conduct a prospective cohort study including couples with a diagnosis of unexplained subfertility. Couples consulting their general practitioner with an unfulfilled child wish will be offered to use FertiScreen. FertiScreen is an online application, in which patients are asked questions about their fertility problem (ie menstrual cycle, age, duration of child wish and the results of the Chlamydia Trachomatis antibody titre and semen analysis). FertiScreen then uses the validated prediction model of Hunault to calculate couples' chance of natural conception during the next twelve months. In addition, patients can find links to extra information concerning subfertility. Couples can then initiate an online consultation with their general practitioner and a gynaecologist, in order to discuss their results and prognosis. When the calculated prognosis of spontaneous conception within one year is >30%, tailored expectant management for 6-12 months will be advised, as no benefit can be expected from fertility treatment.

Questionnaires will be sent to patients as well as to their caregivers (general practitioner, gynaecologist). These questionnaires will focus on the use of FertiScreen (System Usability Scale) and the different domains of quality of care (effectiveness, cost-effectiveness, safety, patient-centredness). For the latter, the investigators use the Hospital Anxiety and Depression Scale and the Patient Centredness Questionnaire for Infertility.

In order to be able to draw conclusions, the investigators will conduct a baseline measurement among couples with unexplained subfertility who have been referred to a fertility clinic. Their data will be abstracted from their medical records and they will receive the aforementioned questionnaires as well (except for the System Usability Scale).

The investigators will recruit couples presenting to general practitioners in the Nijmegen area (which for second line treatment consists of one general hospital and one academic hospital). To detect an increase in guideline adherence of the current 60% to 75% with a power of 80% (P<0,05), the investigators need to include 152 couples in the before as well as in the after measurement.


Recruitment information / eligibility

Status Recruiting
Enrollment 152
Est. completion date
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 37 Years
Eligibility Inclusion Criteria:

- couple consulting their general practitioner with subfertility

- women >18 years and <38 years

- one of the partners Dutch speaking

- access to the Internet

- residing in the Netherlands

- unfulfilled childwish for at least 6 months

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms

  • Unexplained Subfertile Couples With a Good Prognosis.

Intervention

Other:
FertiScreen
FertiScreen is an online application to assess whether referral is necessary or expectant management is indicated.

Locations

Country Name City State
Netherlands Radboud University Nijmegen Medical Centre Nijmegen PO Box 9101

Sponsors (1)

Lead Sponsor Collaborator
Radboud University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other effects on quality of care Efficiency: economic analysis (number of consultations in the second line and the number of diagnostic tests carried out.
Safety: we will measure complaints of anxiety and depression and quality of life at a patient level.
Future implications: we will give advises for implementation strategy to optimize use of FertiScreen.
two years No
Primary Effectiveness of the application: adherence to tailored expectant management The adherence to tailored expectant management: measured by the percentage of patients with unexplained infertility with a good prognosis of spontaneous conception within one year (>30%) with tailored expectant management. Two years No
Secondary experiences with FertiScreen Among the patients the focus will be on ease of use, speed of use, sense of privacy, the extent to which the experience meet previous expectations and the recognisability of the given advise. Among health care providers, the evaluation will focus on the experienced changes in the daily care. two years No